Budapest, Hungary

Otto Clauder


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1978-1979

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Otto Clauder: Innovator in Pharmaceutical Chemistry

Introduction

Otto Clauder is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.

Latest Patents

Clauder holds 2 patents, with his latest innovations focusing on new compounds for medical applications. One of his patents, titled "3.alpha.,16.alpha.-14,15-Dihydroeburnamenine," describes a new compound vincane, which is prepared through specific chemical processes. This compound is derived from vincamenine or vincanol and has potential applications in treating arteriosclerosis and high blood pressure. Another patent, "14-Substituted vincanes," outlines a compound formula that includes various functional groups, enhancing its therapeutic potential.

Career Highlights

Otto Clauder is associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on innovative research and development in the pharmaceutical sector.

Collaborations

Throughout his career, Clauder has collaborated with esteemed colleagues such as Jozsef Kokosi and Laszlo Szporny. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Otto Clauder's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the treatment of significant health conditions, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…